Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer
about
Ovarian Cancer Molecular Stratification and Tumor Heterogeneity: A Necessity and a ChallengeInvestigation of Exomic Variants Associated with Overall Survival in Ovarian Cancer.Distinct implications of different BRCA mutations: efficacy of cytotoxic chemotherapy, PARP inhibition and clinical outcome in ovarian cancerA risk prediction algorithm for ovarian cancer incorporating BRCA1, BRCA2, common alleles and other familial effectsGenome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium.Downregulation of the cancer susceptibility protein WRAP53β in epithelial ovarian cancer leads to defective DNA repair and poor clinical outcomeCataloging antineoplastic agents according to their effectiveness against platinum-resistant and platinum-sensitive ovarian carcinoma cell lines.Ovarian cancer in BRCA1 and BRCA2 gene mutation carriers: analysis of prognostic factors and survival.Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patientsGenetic and molecular changes in ovarian cancer.New paradigms for BRCA1/BRCA2 testing in women with ovarian cancer: results of the Genetic Testing in Epithelial Ovarian Cancer (GTEOC) study.Prognostic significance of BRCA mutations in ovarian cancer: an updated systematic review with meta-analysis.Marriage is a dependent risk factor for mortality of colon adenocarcinoma without a time-varying effectSelecting Patients with Ovarian Cancer for Germline BRCA Mutation Testing: Findings from Guidelines and a Systematic Literature Review.CRISPR/Cas9-Mediated Trp53 and Brca2 Knockout to Generate Improved Murine Models of Ovarian High-Grade Serous Carcinoma.Recent advances in targeting DNA repair pathways for the treatment of ovarian cancer and their clinical relevance.Human Papillomavirus Genotypes and Methylation of CADM1, PAX1, MAL and ADCYAP1 Genes in Epithelial Ovarian Cancer PatientsYoung Israeli women with epithelial ovarian cancer: prevalence of BRCA mutations and clinical correlates.Significant association of the EXO1 rs851797 polymorphism with clinical outcome of ovarian cancer.Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.When to Consider Risk-Reducing Mastectomy in BRCA1/BRCA2 Mutation Carriers with Advanced Stage Ovarian Cancer: a Case Study Illustrating the Genetic Counseling Challenges.Enhanced response rate to pegylated liposomal doxorubicin in high grade serous ovarian carcinomas harbouring BRCA1 and BRCA2 aberrations.CRISPR/Cas9-derived models of ovarian high grade serous carcinoma targeting Brca1, Pten and Nf1, and correlation with platinum sensitivity.Clinicopathologic characteristics associated with long-term survival in advanced epithelial ovarian cancer: an NRG Oncology/Gynecologic Oncology Group ancillary data study.Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study.Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study.Ovarian Cancers: Genetic Abnormalities, Tumor Heterogeneity and Progression, Clonal Evolution and Cancer Stem Cells.Association of BRCA1/2 mutations with ovarian cancer prognosis: An updated meta-analysis.
P2860
Q26777846-8D96D457-7B50-4080-BB69-0A377E279DBEQ30277784-5D491C95-6B64-4024-A35B-9AF2ABCF9923Q33704050-A3B9A783-BEDA-45F7-BBEC-F900BCDCEFDDQ35848518-3E97CD18-5463-4CE5-AA46-491614396914Q36218993-C34CB642-48DB-47D3-A179-169848B32E8CQ36246404-29EC16D3-83EC-470A-A97B-A084578FD016Q36787695-EB108E2C-8487-47B7-B208-940A5AFB3A3FQ36983535-E8F4E63F-2098-42C0-875F-234605504524Q37089636-18E59250-D51E-4BF0-9FA5-5D67B228F8B6Q37094076-061ADC84-37E0-4BC4-9313-B4A18CBE5292Q37398841-06E55055-DFEC-4F05-B6EB-1F07F12F177DQ37702214-9729623B-4669-424C-A564-0BD066C36B6DQ37746233-52558579-AACA-4D7A-9C43-BFC353039AACQ38711217-8DA781D5-4B6D-4CB2-99A3-A071C6C695D1Q38751550-741B4151-BEEE-4343-BA4F-4BBF0DF1BAD2Q39309080-FE59D4B4-0BA1-4D6E-AC09-BBAEFEDEB8A9Q40316397-E6A71563-16C4-424E-B2ED-5FD6708CD509Q41218646-38DFA7F3-865F-43A8-A9D9-584B8AAA58A1Q42373192-9C804656-91CC-4498-9F4C-0CC3409A88FBQ43924266-D271710A-14BA-4F5D-AB6D-27EA2764220BQ47101331-9CDFDDC2-BD42-454B-8A12-DA0A675F6384Q47140496-7F61754C-A960-4A11-A1A1-46779638A18AQ47141255-E9993068-90F7-408A-875A-8217F1F6883FQ47281811-790B6C82-9E36-4E4E-A358-662E9C36ADBAQ47552886-77BA844E-36BC-407D-B217-A1456F120529Q47958061-7EEAF446-E4C2-487A-B8F7-14A9E4D2DB6DQ48124146-52586929-824B-46A7-AD66-FAD287A7D413Q55377222-1B656AEC-107B-4B9A-B079-DE8F191410ED
P2860
Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Germline mutation in BRCA1 or ...... with epithelial ovarian cancer
@ast
Germline mutation in BRCA1 or ...... with epithelial ovarian cancer
@en
type
label
Germline mutation in BRCA1 or ...... with epithelial ovarian cancer
@ast
Germline mutation in BRCA1 or ...... with epithelial ovarian cancer
@en
prefLabel
Germline mutation in BRCA1 or ...... with epithelial ovarian cancer
@ast
Germline mutation in BRCA1 or ...... with epithelial ovarian cancer
@en
P2093
P2860
P50
P1476
Germline mutation in BRCA1 or ...... with epithelial ovarian cancer
@en
P2093
Alice S Whittemore
Anna de Fazio
Beth Karlan
Brooke L Fridley
Caroline Michie
Charlie Gourley
Christine Walsh
Elisa Alducci
P2860
P304
P356
10.1158/1078-0432.CCR-14-2497
P407
P50
P577
2014-11-14T00:00:00Z